Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.04
1.6619.81%
At close: Dec 15, 4:00 PM EST
$9.50
-0.54-5.38%
After Hours: 4:15 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy FibroGen (FGEN) stock?
You can purchase shares of FibroGen (NASDAQ:FGEN) through any online brokerage.
Who are FibroGen (FGEN) competitors?
Other companies in FibroGen’s space includes: Serina Therapeutics Inc (AMEX:SER), Skye Bioscience Inc (NASDAQ:SKYE), Intensity Therapeutics Inc (NASDAQ:INTS), Barinthus Biotherapeutics PLC (NASDAQ:BRNS) and Cue Biopharma Inc (NASDAQ:CUE).
What is the forecast, or price target, for FibroGen (FGEN) stock?
FibroGen has a consensus price target of $15.50.
What is the current price for FibroGen (FGEN)?
The stock price for FibroGen (NASDAQ: FGEN) is $9.5 last updated December 15, 2025 at 4:15 PM EST.
Does FibroGen (FGEN) pay a dividend?
There are no upcoming dividends for FibroGen.
When is FibroGen (NASDAQ:FGEN) reporting earnings?
FibroGen does not have any upcoming earnings scheduled.
Is FibroGen (FGEN) going to split?
There is no upcoming split for FibroGen.
What sector and industry does FibroGen (FGEN) operate in?
FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
